PRP group (n:21) | Non-PRP group (n:31) | P value | |
---|---|---|---|
Age (year) | 9.3±3(5-13.7) | 8.9±2.6(5-13.8) | 0.67 |
Gender (female/male) | 9/12 | 16/15 | 0.259 |
Diabetes duration (years) | 0.57±0.5(0.04-1.7) | 4.3±1.5(2.2-8.7) | <0.001 |
Daily insulin dose (u/kg) | 0.35±0.11(0.13-0.5) | 0.81±0.16(0.55-1.25) | <0.001 |
HbA1c (%) (mmol/mol) | 6.4(46)±0.6(-17)((5.2(33)-7.6(60)) | 7.2(55)±0.6(-17)((6.2(44)-8.3(67)) | <0.001 |
IDDAA1C (%)(mmol/mol) | 7.8(62)±0.7(0.16)((6.8(51)-8.9(74)) | 10.3(89)±0.8(-0.15)((8.6(70)-11.9(107)) | <0.001 |
Estimated HbA1c (%) | 6.5±0.8(4.6-8.1) | 7.6 ±0.9(6.1-9.7) | 0.006 |
CP level (pmol/L) (n:17) | 739.8±537.8(288-2582) | 465.6±478.9(102.6-1854) | 0.002 |
PI level (pmol/L)(n:17) | 3.9±3.7(0.64-12.1) | 0.48±0.33(0.04-1.3) | <0.001 |
PI:CP ratio | 0.55 0.0055 ± 0.004(0.00085-0.15) | 0.13 0.0013 ± 0.001(0.00016-0.003) | <0.001 |